Dare Bioscience, Inc. Balance Sheet
DARE|7 years of annual SEC 10-K data (FY2014-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Dare Bioscience, Inc. had $32M in total assets with negative shareholders' equity of $6M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.7M | $15.7M | $10.5M | $34.7M | $5.5M | $5.5M | $16.7M |
| Current Assets | $27.1M | $18.4M | $17.5M | $43.0M | $77.3M | $77.3M | $52.8M |
| PP&E (Net) | $1.6M | $1.3M | $656.0K | $64.9K | $576.0K | $576.0K | $342.0K |
| Total Assets | $32.5M | $22.1M | $21.3M | $43.8M | $78.2M | $78.2M | $53.4M |
| Current Liabilities | $23.7M | $21.6M | $20.5M | $31.6M | $16.3M | $16.3M | $8.1M |
| Shareholders' Equity | -$6.0M | -$5.0M | $11.1M | $38.8M | -$94.3M | -$94.3M | -$80.0M |